Plain-English translation of NCT06202118 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Breast Cancer research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a treatment called Diffusing Alpha-emitter Radiation Therapy (DaRT), which uses tiny radioactive seeds implanted directly into a breast tumor. The seeds deliver radiation to kill cancer cells from the inside out. This study is specifically designed for older patients (65 and older) or younger patients who are too frail or unfit for standard breast cancer surgery.
Many older and frail patients with breast cancer cannot tolerate traditional surgery or prefer not to have it. This treatment offers an alternative option that may be gentler while still treating the cancer effectively.
You likely qualify if…
You likely don't qualify if…
You will first go through a screening period to confirm you are eligible. If you qualify, you will have a procedure to insert the radioactive seeds directly into your tumor. After that, you'll have follow-up visits during the first 4–8 weeks to check for any immediate side effects, and then regular check-ups over 24 months total. The study will monitor how well the treatment works and whether it is safe for you.
AI-generated summary from trial data · Aug 11, 2026 · Not medical advice
Israel